Sellas Life Sciences

SELLAS™ Life Sciences Appoints Industry Experts to Support Advancement of Cancer Therapeutics Pipeline

Mr. William Pollett appointed Chief Financial Officer; Mr. Martin Baum promoted to Chief Operating Officer Dr. Nicholas Sarlis appointed Senior Vice President, Chief Medical Officer and Dr. Anthony Williams to be Senior Vice President, Head of Clinical Development   ZUG,...
Read More →

SELLAS™ Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma

-Follows Fast Track Designation of Galinpepimut-S for the Treatment of Acute Myeloid Leukemia (AML) ZUG, Switzerland, and NEW YORK, September 19, 2016 /PRNewswire/ — SELLAS™ Life Sciences Group (SELLAS), a development-stage biopharmaceutical company focused on developing...
Read More →